Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
186 participants
OBSERVATIONAL
2025-01-01
2027-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CPAx for Assessing Functional Status of COVID-19 Patients After Intensive Care Unit Discharge
NCT04762056
Fluid Balance and Body Weight Changes in Critically Ill Adult Patients
NCT04434079
Clinical Protocol Validation to Identify Prognostic Markers for Critical Care Pediatric Patients
NCT00792883
Prognostic Score in the Very Old ICU Patients
NCT03370692
Risk Factors of ICU-acquired Weakness
NCT04932330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors
Adult patients admitted to the general ICU at Pedro Ernesto University Hospital (HUPE) who were discharged from the ICU to the hospital ward.
No interventions assigned to this group
Non-Survivors
Adult patients admitted to the general ICU at Pedro Ernesto University Hospital (HUPE) who died during their ICU stay.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Inability to record the CPAx score within the first 48 hours of ICU admission or on the day of ICU discharge
* ICU readmission
* Known comorbidities causing generalized weakness, such as neuromuscular or neurological diseases
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Pedro Ernesto
OTHER
Instituto Nacional de Infectologia Evandro Chagas
UNKNOWN
Universidade Federal do Rio de Janeiro
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jose Roberto Lapa e Silva
Full Professor of Pneumology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PEDRO L SILVA, PhD
Role: STUDY_DIRECTOR
Pulmonary Investigation Laboratory, Carlos Chagas Filho Institute of Biophysics (IBCCF), Federal University of Rio de Janeiro (UFRJ)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pedro Ernesto University Hospital
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
65516422.7.0000.5259
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.